MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer; Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer - Effective July 25, 2021

This Local Coverage Determination (LCD) has completed the Open Public Meeting comment period and is now finalized under contractor numbers: 02101 (AK), 03101 (AZ), 02201 (ID), 03201 (MT), 03301 (ND), 02301 (OR), 03401 (SD), 03501 (UT), 02401 (WA), and 03601 (WY).

Medicare Coverage Database Number LCD Title
L38649 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer

 

Medicare Coverage Database Number Billing and Coding Article
A58187 Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer

 

Effective Date: July 25, 2021
Summary: Coverage of molecular diagnostic tests for use in a beneficiary with bladder cancer when all of the conditions are met.

Visit the Future LCDs webpage to access this LCD.

 

            Last Updated Wed, 26 May 2021 20:14:35 +0000